News on Large Scale Biology Corporation from BioPortfolio.com http://www.BioPortfolio.com Consolidated Large Scale Biology Corporation news from BioPortfolio.com Wed, 10 Feb 2010 09:04:39 GMT en Dynavax Initiates Large-Scale Phase 3 Trial of HEPLISAVhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040175&HITNO=0&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040175&THISHREF=http://c.moreover.com/click/here.pl%3fz2538629444%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040175&HITNO=0&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040175&THISHREF=http://c.moreover.com/click/here.pl%3fz2538629444%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Exome Sequencing Gains Ground as Key Approach for Identifying Genetic Causes of Diseasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038986&HITNO=1&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038986&THISHREF=http://c.moreover.com/click/here.pl%3fz2537861391%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038986&HITNO=1&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038986&THISHREF=http://c.moreover.com/click/here.pl%3fz2537861391%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenomeWeb: Urbanization, export crops drive deforestationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039419&HITNO=2&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039419&THISHREF=http://c.moreover.com/click/here.pl%3fz2538109363%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039419&HITNO=2&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039419&THISHREF=http://c.moreover.com/click/here.pl%3fz2538109363%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Urbanization, export crops drive deforestationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038718&HITNO=3&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038718&THISHREF=http://c.moreover.com/click/here.pl%3fz2537725555%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038718&HITNO=3&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038718&THISHREF=http://c.moreover.com/click/here.pl%3fz2537725555%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comResearch & Development: Medical News: Dynavax Initiates Large-Scale Phase 3 Trial Of HEPLISAVTMhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036818&HITNO=4&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036818&THISHREF=http://c.moreover.com/click/here.pl%3fz2536769775%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036818&HITNO=4&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036818&THISHREF=http://c.moreover.com/click/here.pl%3fz2536769775%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioFind: Dynavax Initiates Large-Scale Phase 3 Trial Of HEPLISAVTMhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036267&HITNO=5&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036267&THISHREF=http://c.moreover.com/click/here.pl%3fz2536544045%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036267&HITNO=5&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036267&THISHREF=http://c.moreover.com/click/here.pl%3fz2536544045%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Dynavax Initiates Large-Scale Phase 3 Trial of HEPLISAV(TM)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033653&HITNO=6&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033653&THISHREF=http://c.moreover.com/click/here.pl%3fz2535307824%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033653&HITNO=6&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033653&THISHREF=http://c.moreover.com/click/here.pl%3fz2535307824%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: Dynavax Initiates Large-Scale Phase 3 Trial of HEPLISAV(TM)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033449&HITNO=7&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033449&THISHREF=http://c.moreover.com/click/here.pl%3fz2535208391%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033449&HITNO=7&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033449&THISHREF=http://c.moreover.com/click/here.pl%3fz2535208391%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Albany Molecular Research Inc. (AMRI) reports 1st Quarter ending March 2010 above estimateshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034006&HITNO=8&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034006&THISHREF=http://c.moreover.com/click/here.pl%3fz2535550509%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034006&HITNO=8&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034006&THISHREF=http://c.moreover.com/click/here.pl%3fz2535550509%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarnings Whispers: One-Third of Antimalarial Medicines Sampled in Three African Nations Found to be Substandard in Large-Scale USP-WHO Studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032316&HITNO=9&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032316&THISHREF=http://c.moreover.com/click/here.pl%3fz2534598977%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032316&HITNO=9&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032316&THISHREF=http://c.moreover.com/click/here.pl%3fz2534598977%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Manufacturing Magazine: Risk of missed doses underestimated, effective guidance programmes neededhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034660&HITNO=10&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034660&THISHREF=http://c.moreover.com/click/here.pl%3fz2535913052%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034660&HITNO=10&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034660&THISHREF=http://c.moreover.com/click/here.pl%3fz2535913052%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Dynavax Initiates Large-Scale Phase 3 Trial of HEPLISAV(TM)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031540&HITNO=11&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031540&THISHREF=http://c.moreover.com/click/here.pl%3fz2534256470%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031540&HITNO=11&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031540&THISHREF=http://c.moreover.com/click/here.pl%3fz2534256470%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: AMRI Announces Fourth Quarter 2009 Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031623&HITNO=12&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031623&THISHREF=http://c.moreover.com/click/here.pl%3fz2534279686%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031623&HITNO=12&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031623&THISHREF=http://c.moreover.com/click/here.pl%3fz2534279686%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: AMRI Announces Fourth Quarter 2009 Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030808&HITNO=13&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030808&THISHREF=http://c.moreover.com/click/here.pl%3fz2533829146%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030808&HITNO=13&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030808&THISHREF=http://c.moreover.com/click/here.pl%3fz2533829146%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: AMRI Announces Fourth Quarter 2009 Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028712&HITNO=14&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028712&THISHREF=http://c.moreover.com/click/here.pl%3fz2532826987%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028712&HITNO=14&MSIZE=127&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Large%20Scale%20Biology%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028712&THISHREF=http://c.moreover.com/click/here.pl%3fz2532826987%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: